Omicron Variant in Mexico: the Fourth COVID-19 Wave.
作者信息
De La Cruz-Hernández Sergio Isaac, Álvarez-Contreras Ana Karen
机构信息
Department of Virology, Institute of Epidemiological Diagnosis and Reference (InDRE), Ministry of Health of Mexico, CDMX, Mexico.
Department of Microbiology, National School of Biological Science, National Polytechnic Institute, CDMX, México.
出版信息
Disaster Med Public Health Prep. 2022 Jun 16:1-2. doi: 10.1017/dmp.2022.160.
Abstract
摘要
相似文献
1
Omicron Variant in Mexico: the Fourth COVID-19 Wave.墨西哥的奥密克戎变种：第四次新冠疫情浪潮
Disaster Med Public Health Prep. 2022 Jun 16:1-2. doi: 10.1017/dmp.2022.160.
2
SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.墨西哥东南部接种疫苗的玛雅人和梅斯蒂索人的 SARS-CoV-2 免疫反应和再感染。
Salud Publica Mex. 2023 Dec 8;66(1, ene-feb):14-16. doi: 10.21149/15186.
3
Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection.奥密克戎感染后 3 个月时既往 COVID-19 疫苗接种对体液免疫的影响，以及奥密克戎感染后 2 个月时第 4 次 COVID-19 疫苗接种的加强效果。
Viruses. 2022 Nov 6;14(11):2458. doi: 10.3390/v14112458.
4
Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City.墨西哥城新冠病毒奥密克戎变种的早期基因组、流行病学和临床描述
Viruses. 2022 Mar 6;14(3):545. doi: 10.3390/v14030545.
5
Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.墨西哥接种疫苗后，德尔塔和奥密克戎 SARS-CoV-2 波期间成年人 COVID-19 不良结局减少。
Front Public Health. 2022 Sep 13;10:1010256. doi: 10.3389/fpubh.2022.1010256. eCollection 2022.
6
Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy.在意大利北部，针对德尔塔和奥密克戎变异株流行期间，于单一意大利 COVID-19 中心住院的接种疫苗患者和未接种疫苗患者的特征和结局。
Int J Infect Dis. 2022 Sep;122:420-426. doi: 10.1016/j.ijid.2022.06.028. Epub 2022 Jun 22.
7
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比，使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
8
Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology.在墨西哥第四波新冠疫情期间，利用基于污水的流行病学方法对奥密克戎和德尔塔变异株的流行情况进行检测与识别。
IJID Reg. 2023 Nov 10;10:44-51. doi: 10.1016/j.ijregi.2023.11.005. eCollection 2024 Mar.
9
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.在墨西哥西部，比较感染野生型 SARS-CoV-2、Delta 或 Omicron 变异株的个体的症状、合并症和再感染的流行情况：一项比较研究。
Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023.
10
Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.中国衢州 2022 年 3 月至 5 月两次疫情期间 COVID-19 疫苗对 SARS-CoV-2 奥密克戎变异株的有效性。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2163813. doi: 10.1080/21645515.2022.2163813. Epub 2023 Jan 27.
引用本文的文献
1
Interpretation of COVID-19 Epidemiological Trends in Mexico Through Wastewater Surveillance Using Simple Machine Learning Algorithms for Rapid Decision-Making.通过使用简单机器学习算法进行废水监测以实现快速决策来解读墨西哥的新冠疫情流行趋势
Viruses. 2025 Jan 15;17(1):109. doi: 10.3390/v17010109.
2
Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology.在墨西哥第四波新冠疫情期间，利用基于污水的流行病学方法对奥密克戎和德尔塔变异株的流行情况进行检测与识别。
IJID Reg. 2023 Nov 10;10:44-51. doi: 10.1016/j.ijregi.2023.11.005. eCollection 2024 Mar.
3
Evaluating the indigenous response to COVID-19 in rural Oaxaca, Mexico.评估墨西哥瓦哈卡州农村地区对新冠疫情的本土应对情况。
J Glob Health. 2023 Oct 6;13:03051. doi: 10.7189/jogh.13.03051.
4
Difference in presentation, outcomes, and hospital epidemiologic trend of COVID-19 among first, second, and third waves: a review of hospital records and prospective cohort study.新冠疫情第一波、第二波和第三波中COVID-19的临床表现、结局及医院流行病学趋势差异：医院记录回顾与前瞻性队列研究
Ann Med Surg (Lond). 2023 Jul 6;85(8):3816-3826. doi: 10.1097/MS9.0000000000001024. eCollection 2023 Aug.
5
Omicron BA.5 Subvariant Provokes the Fifth COVID-19 Wave in Mexico: Closer to the End of This Pandemic.奥密克戎BA.5亚变体在墨西哥引发第五波新冠疫情：这场大流行接近尾声。
Disaster Med Public Health Prep. 2023 Jan 11;17:e344. doi: 10.1017/dmp.2023.14.
本文引用的文献
1
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.美国新英格兰地区 SARS-CoV-2 变异株 Delta 和 Alpha 的比较传染性。
Cell Rep Med. 2022 Mar 11;3(4):100583. doi: 10.1016/j.xcrm.2022.100583. eCollection 2022 Apr 19.
2
Will Omicron finally overpower China's COVID defences?奥密克戎最终会突破中国的新冠防线吗？
Nature. 2022 Apr;604(7904):17-18. doi: 10.1038/d41586-022-00884-z.
3
The Delta variant triggers the third wave of COVID-19 in Mexico.德尔塔变种毒株引发了墨西哥新冠肺炎疫情的第三波高峰。
Disaster Med Public Health Prep. 2022 Feb 21:1-5. doi: 10.1017/dmp.2022.49.
4
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.COVID-19 发病率和死亡率在有和没有加强针的未接种和完全接种成年人中，在德尔塔和奥密克戎变体出现期间-25 个美国司法管辖区，2021 年 4 月 4 日至 12 月 25 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
5
The Emergence of Omicron: Challenging Times Are Here Again!奥密克戎出现：艰难时刻再次来临！
Indian J Pediatr. 2022 May;89(5):490-496. doi: 10.1007/s12098-022-04077-4. Epub 2022 Jan 13.
6
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance.奥密克戎变异株（B.1.1.529）：传染性、疫苗突破和抗体耐药性。
J Chem Inf Model. 2022 Jan 24;62(2):412-422. doi: 10.1021/acs.jcim.1c01451. Epub 2022 Jan 6.
7
Impact of the Delta variant on vaccine efficacy and response strategies.Delta 变异株对疫苗效力和应对策略的影响。
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209. doi: 10.1080/14760584.2021.1976153. Epub 2021 Sep 9.
8
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.在不断演变的 COVID-19 大流行中，关注的 SARS-CoV-2 变体的起源和潜在未来。
Curr Biol. 2021 Jul 26;31(14):R918-R929. doi: 10.1016/j.cub.2021.06.049. Epub 2021 Jun 23.
9
A focus on the spread of the delta variant of SARS-CoV-2 in India.关注严重急性呼吸综合征冠状病毒2（SARS-CoV-2）Delta变种在印度的传播情况。
Indian J Med Res. 2021 May;153(5&6):537-541. doi: 10.4103/ijmr.ijmr_1353_21.
Zotero 插件